Jonathan has a phD in cellular and molecular biology from the university of Strasbourg. After a postdoctoral at the Ludwig Institute for Cancer Research (Lausanne Branch) in innate immunity, Jonathan joined Glenmark Pharmaceuticals in 2010 as senior research Officer. He holds now a position of Project Team Leader within the Biotherapeutic Discovery department in Switzerland. Within Glenmark, as discovery project lead, Jonathan contributed to the development of 2 BEAT antibodies and one “standard” antibody, now in clinical phase for cancer or autoimmune diseases respectively. Jonathan has experience in designing and conducting discovery and translational development for immune-based biologics and notably T cell redirecting programs. Jonathan is also lecturer in immunology at the University of Neuchâtel.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October